Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Measles virus proteins refer to the ensemble of proteins encoded by the measles virus, a negative-sense, single-stranded RNA virus of the genus Morbillivirus (family Paramyxoviridae)[7][9]. The major structural proteins include: - **Nucleoprotein (N)**, which binds the viral RNA, forming the nucleocapsid[6]. - **Phosphoprotein (P)**, a polymerase cofactor required for RNA replication and transcription[3][6]. - **Matrix protein (M)**, which links the ribonucleoprotein complex to the viral envelope, organizing virus assembly and budding[1][5]. - **Fusion protein (F)**, responsible for membrane fusion and cell entry[4][7]. - **Hemagglutinin (H)**, mediates viral attachment to host cell receptors (notably CD46, SLAMF1/CD150, and Nectin-4)[4][7]. - **Large protein (L)**, functions as the RNA-dependent RNA polymerase[3][6]. There are also non-structural proteins **C and V** encoded by the P gene, which antagonize host immune responses and regulate viral RNA synthesis[8][7][3]. Each protein has distinct roles and, when targeted individually (such as the Fusion or Hemagglutinin proteins), may serve as a discrete antiviral target. However, "Measles virus proteins" as a category is not itself a single drug target and should be replaced with a specific protein as appropriate for structured drug discovery or therapeutic targeting purposes[3][7][1]. For drug targeting, the **Hemagglutinin (H)** and **Fusion (F)** proteins are considered the most promising antiviral targets, and several investigational inhibitors have been designed to block viral entry, though none are approved[7].
Not applicable as a group (individual proteins: e.g. fusion inhibition, polymerase inhibition, receptor blockade)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Measles virus proteins.